论文部分内容阅读
本文回顾分析我院1986年5月至1990年8月间,54例早产者应用硫酸舒喘灵抑制宫缩治疗的临床资料,并与同期47例早产未用宫缩抑制剂者作对照.结果显示:硫酸舒喘灵组抑制宫缩成功45例,成功率为83.33%,平均延长妊娠时7.47天,最长达28天;对照组仅1例宫缩自行缓解,余全部在48小时内分娩.硫酸舒喘灵组新生儿窒息率低于对照组,产后出血率及出血量两组无差异.仅2例服硫酸舒喘灵后出现心动过速,停药后自行缓解.故认为对早产应用硫酸舒喘灵抑制宫缩治疗安全、有效.
This retrospective analysis of our hospital from May 1986 to August 1990, 54 cases of preterm labor application of sutra sulfate sulfate inhibition of uterine contractions clinical data, and with the same period 47 cases of premature uterine contractions were used as a control.Results The results showed that 45 cases of uterine contractions were inhibited by salbutamol sulfate group with a success rate of 83.33% and an average prolongation of 7.47 days during pregnancy, up to 28 days. In the control group, only 1 case contracted spontaneous contractions, all of which were delivered within 48 hours .The rate of neonatal asphyxia in the sulphate sulfate group was lower than that in the control group, there was no difference in the rate of postpartum hemorrhage and the amount of bleeding.Only two patients with tachycardia after taking salbutamol sulfate appeared to relieve spontaneously after withdrawal, therefore, Sulfate sulfate inhibition of contractions treatment safe and effective.